首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1259876

頭頸椎癌的全球市場:各類藥物，COPD各類型，各治療類型，各流通管道，各地區，市場區隔預測(2023年～2032年)

Head and Neck Cancer Market, [By Cancer Type ; By Diagnostic Techniques; By Treatment Type; By End Use; and Geography - Trend, Analysis and Forecast till 2032

出版日期: 2023年03月01日 | 出版商:

Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球頭頸椎癌的市場規模到2032年前將達到45億2,343萬美元。

本報告提供全球頭頸椎癌市場相關調查分析，提供目前市場動態的考察，及未來市場成長的相關分析等資訊。

主要調查結果
簡介
頭頸椎癌市場 - 北美
- 北美的頭頸椎癌市場:各類藥物(2019年～2032年)
- 北美的頭頸椎癌市場:COPD各類型(2019年～2032年)
- 北美的頭頸椎癌市場:各治療類型(2019年～2032年)
- 北美的頭頸椎癌市場:各流通管道(2019年～2032年)
- 頭頸椎癌市場 - 美國
- 頭頸椎癌市場 - 加拿大
頭頸椎癌市場 - 歐洲
- 歐洲的頭頸椎癌市場:各類藥物(2019年～2032年)
- 歐洲的頭頸椎癌市場:COPD各類型(2019年～2032年)
- 歐洲的頭頸椎癌市場:各治療類型(2019年～2032年)
- 歐洲的頭頸椎癌市場:各流通管道(2019年～2032年)
- 頭頸椎癌市場 - 英國
- 頭頸椎癌市場 - 法國
- 頭頸椎癌市場 - 德國
- 頭頸椎癌市場 - 義大利
- 頭頸椎癌市場 - 西班牙
- 頭頸椎癌市場 - 荷蘭
- 頭頸椎癌市場 - 俄羅斯
頭頸椎癌市場 - 亞太地區
- 亞太地區的頭頸椎癌市場:各類藥物(2019年～2032年)
- 亞太地區的頭頸椎癌市場:COPD各類型(2019年～2032年)
- 亞太地區的頭頸椎癌市場:各治療類型(2019年～2032年)
- 亞太地區的頭頸椎癌市場:各流通管道(2019年～2032年)
- 頭頸椎癌市場 - 中國
- 頭頸椎癌市場 - 印度
- 頭頸椎癌市場 - 日本
- 頭頸椎癌市場 - 馬來西亞
- 頭頸椎癌市場 - 印尼
- 頭頸椎癌市場 - 韓國
頭頸椎癌市場 - 中東·非洲
- 中東·非洲的頭頸椎癌市場:各類藥物(2019年～2032年)
- 中東·非洲的頭頸椎癌市場:COPD各類型(2019年～2032年)
- 中東·非洲的頭頸椎癌市場:各治療類型(2019年～2032年)
- 中東·非洲的頭頸椎癌市場:各流通管道(2019年～2032年)
- 頭頸椎癌市場 - 沙烏地阿拉伯
- 頭頸椎癌市場 - 南非
- 頭頸椎癌市場 - 以色列
- 頭頸椎癌市場 - 阿拉伯聯合大公國
頭頸椎癌市場 - 南美
- 南美的頭頸椎癌市場:各類藥物(2019年～2032年)
- 南美的頭頸椎癌市場:COPD各類型(2019年～2032年)
- 南美的頭頸椎癌市場:各治療類型(2019年～2032年)
- 南美的頭頸椎癌市場:各流通管道(2019年～2032年)
- 頭頸椎癌市場 - 墨西哥
- 頭頸椎癌市場 - 巴西
- 頭頸椎癌市場 - 阿根廷

第10章競爭情形

擴張和收購的分析
- 擴張
- 收購
夥伴關係/聯盟/協定/公開

第11章企業簡介

Bayer Healthcare AG
Boston Biomedical, Inc
Bristol-Myers Squibb Company
Astellas Pharma Inc
AbbVie Inc
AstraZeneca Plc.
Acceleron Pharma Inc
DentalEZ, Inc.
Koninklijke Philips N.V
Siemens Healthcare Private Limited
AB Sciences
AdDent Incorporated

簡介目錄圖表

Product Code: PM1330

The global head and neck cancer market size is expected to reach USD 4,523.43 million by 2032, according to a new study by Polaris Market Research. The report "Head and Neck cancer Market, By Drug Class (Phosphodiestrase-4 Inhibitors, Anti-PD-1 Monoclonal Antibodies, Long-Acting Bronchodilators, Short-Acting Bronchodilators, Methylxanthines, Corticosteroids), By COPD Type; By Treatment Type: By Distribution Channel: By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The head and neck cancer industry is expected to grow at the quickest rate over the forecast period owing to increasing global alcohol and tobacco-consuming consumers and the geriatric population.

Head and neck cancer disorders are generally characterized by cancer in the squamous cells present in the lining of the mouth, voice box (larynx), and throat (pharynx). The disorder can also be found in various parts such as sinuses, salivary glands, and muscles or nerves.

Head and neck cancer is considered the seventh most common cancer globally and contributes to more than 8,00,000 new cases annually, as per the National library of medicine. As per the National Institute of Cancer, the major reasons for head and neck cancer disorder can be attributed to continuous alcohol and tobacco use, infection with cancer-causing human papillomavirus, occupational exposure, radiation exposure, and other underlying genetic condition. Common symptoms witnessed in the disorder are a lump in the neck, sore mouth, difficulty swallowing, hoarseness in the voice, white or red patches on the gums, bleeding through the nose, swelling under the chin, and numbness or paralysis of the muscles in the face.

The major restraining factors for the head and neck cancer market are expensive diagnosis therapies and the unavailability of well-developed cancer treatment clinics across underdeveloped countries.

Head and neck cancer Market Report Highlights:

The COVID-19 pandemic harmed the head and neck cancer market. Factors such as limited inpatient services, fear of contact with healthcare providers, and telemedical visits during the pandemic led to a delayed diagnosis for the head and neck cancer market.

In the drug class, the anti-PD-monoclonal antibodies segment is anticipated to dominate the market. The major factor behind the growth can be attributed to the higher efficiency of the drug against the cancer cells. Monoclonal antibodies such as PD-1 and PD-L1 effectively target the checkpoint proteins that attack the body's cancer cells.

In the distribution channel segment, the hospital pharmacy is anticipated to dominate the market in 2022 due to increasing demand for cancer-treating drugs and therapies from rising admission of head and neck cancer patients in private hospitals and public hospitals globally.

In the forecast period, the North America region is projected to dominate the head and neck cancer market owing to a larger share of patients and their expenditure on treating head and neck cancer. The continuous R&D on new drugs and drugs approved by the US Food and Drug Administration (FDA) has increased the demand for more effective therapies from all over the world and further fueled the market in the region.

Polaris Market Research has segmented the Head and neck cancer Market report based on Drug class, COPD type, treatment type, distribution channel, and region:

Head and neck cancer Market, Drug class Outlook (Revenue - USD Million, 2019 - 2032)

Phosphodiestrase-4 Inhibitors

Anti-PD-1 Monoclonal Antibodies

Long-Acting Bronchodilators

Short-Acting Bronchodilators

Methylxanthines

Corticosteroids

Head and neck cancer Market, COPD Outlook (Revenue - USD Million, 2019 - 2032)

Chronic Bronchitis

Emphysema

Head and neck cancer Market, Treatment Type Outlook (Revenue - USD Million, 2019- 2032)

Drugs

Oxygen therapy

Surgery

Others

Head and neck cancer Market, Distribution Channel Outlook (Revenue - USD Million, 2019- 2032)

Hospitals Pharmacies

E-Commerce

Retail Pharmacies

Head and neck cancer Market, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Head and Neck Cancer Market Insights

4.1. Head and Neck Cancer - Industry Snapshot
4.2. Head and Neck Cancer Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing prevalence of head and neck cancers
  - 4.2.1.2. Rising geriatric population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of treatments
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Head and Neck Cancer Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Head and Neck Cancer Market, by Drug Class

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
5.3. Phosphodiestrase-4 Inhibitors
- 5.3.1. Global Head and Neck Cancer Market, by Phosphodiestrase-4 Inhibitors, by Region, 2019-2032 (USD Million)
5.4. Anti-PD-1 Monoclonal Antibodies
- 5.4.1. Global Head and Neck Cancer Market, by Anti-PD-1 Monoclonal Antibodies, by Region, 2019-2032 (USD Million)
5.5. Long-Acting Bronchodilators
- 5.5.1. Global Head and Neck Cancer Market, by Long-Acting Bronchodilators, by Region, 2019-2032 (USD Million)
5.6. Short-Acting Bronchodilators
- 5.6.1. Global Head and Neck Cancer Market, by Short-Acting Bronchodilators, by Region, 2019-2032 (USD Million)
5.7. Methylxanthines
- 5.7.1. Global Head and Neck Cancer Market, by Methylxanthines, by Region, 2019-2032 (USD Million)
5.8. Corticosteroids
- 5.8.1. Global Head and Neck Cancer Market, by Corticosteroids, by Region, 2019-2032 (USD Million)

6. Global Head and Neck Cancer Market, by Treatment Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
6.3. Drugs
- 6.3.1. Global Head and Neck Cancer Market, by Drugs, by Region, 2019-2032 (USD Million)
6.4. Oxygen therapy
- 6.4.1. Global Head and Neck Cancer Market, by Oxygen therapy, by Region, 2019-2032 (USD Million)
6.5. Surgery
- 6.5.1. Global Head and Neck Cancer Market, by Surgery, by Region, 2019-2032 (USD Million)
6.6. Others
- 6.6.1. Global Head and Neck Cancer Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Head and Neck Cancer Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
7.3. Hospitals Pharmacies
- 7.3.1. Global Head and Neck Cancer Market, by Hospitals Pharmacies, by Region, 2019-2032 (USD Million)
7.4. E-Commerce
- 7.4.1. Global Head and Neck Cancer Market, by E-Commerce, by Region, 2019-2032 (USD Million)
7.5. Retail Pharmacies
- 7.5.1. Global Head and Neck Cancer Market, by Retail Pharmacies, by Region, 2019-2032 (USD Million)

8. Global Head and Neck Cancer Market, by COPD Type

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
8.3. Chronic Bronchitis
- 8.3.1. Global Head and Neck Cancer Market, by Chronic Bronchitis, by Region, 2019-2032 (USD Million)
8.4. Emphysema
- 8.4.1. Global Head and Neck Cancer Market, by Emphysema, by Region, 2019-2032 (USD Million)

9. Global Head and Neck Cancer Market, by Geography

9.1. Key findings
9.2. Introduction
- 9.2.1. Head and Neck Cancer Market Assessment, By Geography, 2019-2032 (USD Million)
9.3. Head and Neck Cancer Market - North America
- 9.3.1. North America: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
- 9.3.2. North America: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
- 9.3.3. North America: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
- 9.3.4. North America: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.3.5. Head and Neck Cancer Market - U.S.
  - 9.3.5.1. U.S.: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.3.5.2. U.S.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.3.5.3. U.S.: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.3.5.4. U.S.: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.3.6. Head and Neck Cancer Market - Canada
  - 9.3.6.1. Canada: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.3.6.2. Canada: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.3.6.3. Canada: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.3.6.4. Canada: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
9.4. Head and Neck Cancer Market - Europe
- 9.4.1. Europe: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
- 9.4.2. Europe: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
- 9.4.3. Europe: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
- 9.4.4. Europe: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.5. Head and Neck Cancer Market - UK
  - 9.4.5.1. UK: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.5.2. UK: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.4.5.3. UK: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.4.5.4. UK: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.6. Head and Neck Cancer Market - France
  - 9.4.6.1. France: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.6.2. France: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.4.6.3. France: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.4.6.4. France: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.7. Head and Neck Cancer Market - Germany
  - 9.4.7.1. Germany: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.7.2. Germany: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.4.7.3. Germany: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.4.7.4. Germany: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.8. Head and Neck Cancer Market - Italy
  - 9.4.8.1. Italy: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.8.2. Italy: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.4.8.3. Italy: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.4.8.4. Italy: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.9. Head and Neck Cancer Market - Spain
  - 9.4.9.1. Spain: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.9.2. Spain: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.4.9.3. Spain: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.4.9.4. Spain: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.10. Head and Neck Cancer Market - Netherlands
  - 9.4.10.1. Netherlands: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.10.2. Netherlands: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.4.10.3. Netherlands: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.4.10.4. Netherlands: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.11. Head and Neck Cancer Market - Russia
  - 9.4.11.1. Russia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.11.2. Russia.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.4.11.3. Russia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.4.11.4. Russia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
9.5. Head and Neck Cancer Market - Asia Pacific
- 9.5.1. Asia Pacific: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.5.5. Head and Neck Cancer Market - China
  - 9.5.5.1. China: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.5.2. China.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.5.5.3. China: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.5.5.4. China: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.5.6. Head and Neck Cancer Market - India
  - 9.5.6.1. India: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.6.2. India.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.5.6.3. India: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.5.6.4. India: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.5.7. Head and Neck Cancer Market - Japan
  - 9.5.7.1. Japan: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.7.2. Japan.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.5.7.3. Japan: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.5.7.4. Japan: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.5.8. Head and Neck Cancer Market - Malaysia
  - 9.5.8.1. Malaysia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.8.2. Malaysia.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.5.8.3. Malaysia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.5.8.4. Malaysia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.5.9. Head and Neck Cancer Market - Indonesia
  - 9.5.9.1. Indonesia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.9.2. Indonesia.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.5.9.3. Indonesia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.5.9.4. Indonesia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.5.10. Head and Neck Cancer Market - South Korea
  - 9.5.10.1. South Korea: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.10.2. South Korea.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.5.10.3. South Korea: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.5.10.4. South Korea: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
9.6. Head and Neck Cancer Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.6.5. Head and Neck Cancer Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.5.2. Saudi Arabia: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.6.5.3. Saudi Arabia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.6.5.4. Saudi Arabia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.6.6. Head and Neck Cancer Market - South Africa
  - 9.6.6.1. South Africa: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.6.2. South Africa: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.6.6.3. South Africa: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.6.6.4. South Africa: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.6.7. Head and Neck Cancer Market - Israel
  - 9.6.7.1. Israel: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.7.2. Israel: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.6.7.3. Israel: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.6.7.4. Israel: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.6.8. Head and Neck Cancer Market - UAE
  - 9.6.8.1. UAE: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.8.2. UAE: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.6.8.3. UAE: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.6.8.4. UAE: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
9.7. Head and Neck Cancer Market - Latin America
- 9.7.1. Latin America: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
- 9.7.2. Latin America: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
- 9.7.3. Latin America: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
- 9.7.4. Latin America: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.7.5. Head and Neck Cancer Market - Mexico
  - 9.7.5.1. Mexico: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.7.5.2. Mexico: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.7.5.3. Mexico: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.7.5.4. Mexico: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.7.6. Head and Neck Cancer Market - Brazil
  - 9.7.6.1. Brazil: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.7.6.2. Brazil: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.7.6.3. Brazil: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.7.6.4. Brazil: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.7.7. Head and Neck Cancer Market - Argentina
  - 9.7.7.1. Argentina: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
  - 9.7.7.2. Argentina: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
  - 9.7.7.3. Argentina: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
  - 9.7.7.4. Argentina: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Bayer Healthcare AG
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Boston Biomedical, Inc
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bristol-Myers Squibb Company
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Astellas Pharma Inc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. AbbVie Inc
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. AstraZeneca Plc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Acceleron Pharma Inc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. DentalEZ, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Koninklijke Philips N.V
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Siemens Healthcare Private Limited
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. AB Sciences
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. AdDent Incorporated
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Head and Neck Cancer Market, by Drug Class, by Region, 2019-2032 (USD Million)
Table 2 Global Head and Neck Cancer Market, by Treatment Type, by Region, 2019-2032 (USD Million)
Table 3 Global Head and Neck Cancer Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
Table 4 Global Head and Neck Cancer Market, by COPD Type, by Region, 2019-2032 (USD Million)
Table 5 Head and Neck Cancer Market Assessment, By Geography, 2019-2032 (USD Million)
Table 6 North America: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 7 North America: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 8 North America: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 9 North America: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 10 U.S.: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 11 U.S.: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 12 U.S.: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 13 U.S.: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 14 Canada: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 15 Canada: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 16 Canada: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 17 Canada: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 18 Europe: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 19 Europe: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 20 Europe: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 21 Europe: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 22 Germany: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 23 Germany: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 24 Germany: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 25 Germany: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 26 France: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 27 France: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 28 France: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 29 France: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 30 UK: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 31 UK: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 32 UK: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 33 UK: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 34 Italy: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 35 Italy: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 36 Italy: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 37 Italy: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 38 Netherlands: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 39 Netherlands: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 40 Netherlands: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 41 Netherlands: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 42 Spain: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 43 Spain: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 44 Spain: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 45 Spain: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 46 Russia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 47 Russia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 48 Russia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 49 Russia: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 50 Asia Pacific: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 51 Asia Pacific: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 52 Asia Pacific: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 53 Asia Pacific: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 54 China: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 55 China: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 56 China: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 57 China: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 58 Japan: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 59 Japan: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 60 Japan: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 61 Japan: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 62 India: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 63 India: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 64 India: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 65 India: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 66 Indonesia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 67 Indonesia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 68 Indonesia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 69 Indonesia: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 70 Malaysia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 71 Malaysia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 72 Malaysia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 73 Malaysia: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 74 South Korea: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 75 South Korea: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 76 South Korea: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 77 South Korea: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 78 Latin America: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 79 Latin America: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 80 Latin America: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 81 Latin America: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 82 Brazil: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 83 Brazil: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 84 Brazil: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 85 Brazil: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 86 Mexico: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 87 Mexico: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 88 Mexico: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 89 Mexico: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 90 Argentina: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 91 Argentina: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 92 Argentina: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 93 Argentina: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 94 Middle East & Africa: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 95 Middle East & Africa: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 96 Middle East & Africa: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 97 Middle East & Africa: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 98 UAE: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 99 UAE: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 100 UAE: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 101 UAE: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 102 Saudi Arabia: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 103 Saudi Arabia: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 104 Saudi Arabia: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 105 Saudi Arabia: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 106 South Africa: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 107 South Africa: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 108 South Africa: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 109 South Africa: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)
Table 110 Israel: Head and Neck Cancer Market, by Drug Class, 2019-2032 (USD Million)
Table 111 Israel: Head and Neck Cancer Market, by Treatment Type, 2019-2032 (USD Million)
Table 112 Israel: Head and Neck Cancer Market, by Distribution Channel, 2019-2032 (USD Million)
Table 113 Israel: Head and Neck Cancer Market, by COPD Type, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Head and Neck Cancer Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up COPD Type
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Drug Class
Figure 7. Global Head and Neck Cancer Market, by Drug Class, 2021 & 2030 (USD Million)
Figure 8. Market by COPD Type
Figure 9. Global Head and Neck Cancer Market, by COPD Type, 2021 & 2030 (USD Million)
Figure 10. Market by Treatment Type
Figure 11. Global Head and Neck Cancer Market, by Treatment Type, 2021 & 2030 (USD Million)
Figure 12. Market by Distribution Channel
Figure 13. Global Head and Neck Cancer Market, by Distribution Channel, 2021 & 2030 (USD Million)